Petros Pharmaceuticals (PTPI) stock Forecast for 2021 – 2025

Petros Pharmaceuticals (PTPI) stock Forecast for 2022 – 2026

Last update: 05-17-2022, 17:12

Sector: Healthcare

The share price of Petros Pharmaceuticals, Inc. (PTPI) now

What analysts predict:: $None

52-week high/low: $5.2 / $0.863

50/200 Day Moving Average: $1.207 / $1.963

This figure corresponds to the average price over the previous 50/200 days. For Petros Pharmaceuticals stocks, the 50-day moving average is the resistance level today.

For Petros Pharmaceuticals stocks, the 200-day moving average is the resistance level today.

Are you interested in Petros Pharmaceuticals, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Petros Pharmaceuticals stock price in 2022, 2023, 2024, 2025, 2026. How much will one Petros Pharmaceuticals share be worth in 2022 - 2026?

When should I take profit in Petros Pharmaceuticals stock? When should I record a loss on Petros Pharmaceuticals stock? What are analysts' forecasts for Petros Pharmaceuticals stock? What is the future of Petros Pharmaceuticals stock?

We forecast Petros Pharmaceuticals stock performance using neural networks based on historical data on Petros Pharmaceuticals stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Petros Pharmaceuticals stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2022, 2023, 2024, 2025 and 2026)

The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Petros Pharmaceuticals shares. This happens once a day.




Historical and forecast chart of Petros Pharmaceuticals stock

The chart below shows the historical price of Petros Pharmaceuticals stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Petros Pharmaceuticals stock price can be found in the table below.

Long-term forecasts by years.

Petros Pharmaceuticals daily forecast for a month

Date Target Pes. Opt. Vol., %
May 19 0.99 0.96 1.01 5.17
May 20 0.98 0.94 1.00 6.29
May 21 0.93 0.92 0.96 4.88
May 22 0.91 0.90 0.93 4.16
May 23 0.96 0.91 1.01 10.97
May 24 0.97 0.93 1.02 10.21
May 25 0.98 0.96 1.03 7.31
May 26 1.00 0.98 1.04 5.61
May 27 1.03 0.99 1.07 8.47
May 28 1.05 1.00 1.09 8.52
May 29 1.07 1.04 1.10 5.77
May 30 1.12 1.11 1.16 4.89
May 31 1.19 1.17 1.25 6.37
Jun 01 1.21 1.17 1.26 7.99
Jun 02 1.29 1.25 1.30 3.93
Jun 03 1.33 1.30 1.35 3.37
Jun 04 1.32 1.30 1.35 3.50
Jun 05 1.30 1.28 1.34 4.85
Jun 06 1.25 1.22 1.31 7.57
Jun 07 1.24 1.18 1.26 6.19
Jun 08 1.25 1.21 1.30 7.41
Jun 09 1.29 1.27 1.31 3.18
Jun 10 1.36 1.30 1.42 9.10
Jun 11 1.35 1.29 1.37 6.23
Jun 12 1.36 1.30 1.37 5.63
Jun 13 1.44 1.42 1.49 5.49
Jun 14 1.38 1.36 1.41 3.90
Jun 15 1.37 1.32 1.42 7.22
Jun 16 1.32 1.29 1.37 6.12
Jun 17 1.34 1.28 1.39 8.31

Petros Pharmaceuticals Daily Price Targets


Petros Pharmaceuticals Stock Forecast 05-19-2022.

Forecast target price for 05-19-2022: $0.99. Positive dynamics for Petros Pharmaceuticals shares will prevail with possible volatility of 4.912%.

Pessimistic target level: 0.96

Optimistic target level: 1.01


Petros Pharmaceuticals Stock Forecast 05-20-2022.

Forecast target price for 05-20-2022: $0.98. Negative dynamics for Petros Pharmaceuticals shares will prevail with possible volatility of 5.918%.

Pessimistic target level: 0.94

Optimistic target level: 1.00


Petros Pharmaceuticals Stock Forecast 05-21-2022.

Forecast target price for 05-21-2022: $0.93. Negative dynamics for Petros Pharmaceuticals shares will prevail with possible volatility of 4.650%.

Pessimistic target level: 0.92

Optimistic target level: 0.96


Petros Pharmaceuticals Stock Forecast 05-22-2022.

Forecast target price for 05-22-2022: $0.91. Negative dynamics for Petros Pharmaceuticals shares will prevail with possible volatility of 3.991%.

Pessimistic target level: 0.90

Optimistic target level: 0.93


Petros Pharmaceuticals Stock Forecast 05-23-2022.

Forecast target price for 05-23-2022: $0.96. Positive dynamics for Petros Pharmaceuticals shares will prevail with possible volatility of 9.886%.

Pessimistic target level: 0.91

Optimistic target level: 1.01


Petros Pharmaceuticals Stock Forecast 05-24-2022.

Forecast target price for 05-24-2022: $0.97. Positive dynamics for Petros Pharmaceuticals shares will prevail with possible volatility of 9.268%.

Pessimistic target level: 0.93

Optimistic target level: 1.02


PTPI (PTPI) Monthly Stock Prediction for 2022

Month Target Pes. Opt. Vol., %
Jun. 1.02 0.94 1.10 14.26
Jul. 1.05 0.91 1.16 22.12
Aug. 0.99 0.92 1.11 16.93
Sep. 0.92 0.78 0.99 21.27
Oct. 0.81 0.70 0.90 22.38
Nov. 0.74 0.64 0.80 19.81
Dec. 0.70 0.65 0.77 15.86

Petros Pharmaceuticals forecast for this year


Petros Pharmaceuticals Stock Prediction for Jun 2022

An uptrend is forecast for this month with an optimal target price of $1.0203. Pessimistic: $0.94. Optimistic: $1.10


Petros Pharmaceuticals Stock Prediction for Jul 2022

An uptrend is forecast for this month with an optimal target price of $1.04683. Pessimistic: $0.91. Optimistic: $1.16


Petros Pharmaceuticals Stock Prediction for Aug 2022

An downtrend is forecast for this month with an optimal target price of $0.988205. Pessimistic: $0.92. Optimistic: $1.11


Petros Pharmaceuticals Stock Prediction for Sep 2022

An downtrend is forecast for this month with an optimal target price of $0.922984. Pessimistic: $0.78. Optimistic: $0.99


Petros Pharmaceuticals Stock Prediction for Oct 2022

An downtrend is forecast for this month with an optimal target price of $0.814072. Pessimistic: $0.70. Optimistic: $0.90


Petros Pharmaceuticals Stock Prediction for Nov 2022

An downtrend is forecast for this month with an optimal target price of $0.744062. Pessimistic: $0.64. Optimistic: $0.80


Petros Pharmaceuticals Stock Prediction for Dec 2022

An downtrend is forecast for this month with an optimal target price of $0.69793. Pessimistic: $0.65. Optimistic: $0.77




Petros Pharmaceuticals (PTPI) Monthly Stock Prediction for 2023

Month Target Pes. Opt. Vol., %
Jan 0.75 0.63 0.85 25.18
Feb 0.75 0.72 0.81 11.65
Mar 0.67 0.60 0.69 13.65
Apr 0.72 0.64 0.82 21.95
May 0.67 0.62 0.72 13.43
Jun 0.76 0.70 0.83 16.18
Jul 0.82 0.77 0.94 18.18
Aug 0.98 0.87 1.10 21.03
Sep 0.99 0.94 1.09 13.84
Oct 1.16 1.04 1.31 20.57
Nov 1.30 1.15 1.42 18.65
Dec 1.19 1.13 1.35 15.72

Petros Pharmaceuticals (PTPI) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
Jan 1.14 0.96 1.24 22.47
Feb 0.95 0.91 1.04 12.45
Mar 0.97 0.92 1.02 9.89
Apr 1.03 0.90 1.10 17.76
May 1.18 1.08 1.26 14.02
Jun 1.22 1.15 1.31 11.94
Jul 1.35 1.25 1.48 15.54
Aug 1.57 1.51 1.73 12.91
Sep 1.37 1.21 1.49 18.53
Oct 1.10 1.04 1.20 13.21
Nov 1.11 1.00 1.26 21.16
Dec 1.06 0.98 1.17 16.09



Petros Pharmaceuticals (PTPI) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 1.23 1.16 1.30 10.65
Feb 1.11 1.00 1.21 17.31
Mar 1.17 1.03 1.24 16.64
Apr 1.30 1.11 1.40 21.19
May 1.52 1.28 1.68 24.05
Jun 1.75 1.66 1.91 13.03
Jul 1.84 1.64 1.93 15.40
Aug 1.78 1.68 1.96 14.29
Sep 1.58 1.45 1.81 20.21
Oct 1.69 1.47 1.90 22.68
Nov 1.78 1.53 1.97 22.66
Dec 1.80 1.52 2.00 23.92

Petros Pharmaceuticals (PTPI) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 2.02 1.91 2.21 13.69
Feb 1.97 1.75 2.22 21.00
Mar 1.90 1.69 2.04 17.10
Apr 2.25 2.11 2.53 16.40
May 2.14 1.96 2.41 18.51
Jun 2.11 2.01 2.33 13.41
Jul 2.39 2.07 2.69 23.27
Aug 2.86 2.67 3.31 19.20
Sep 2.78 2.58 2.94 12.26
Oct 2.55 2.38 2.84 16.34
Nov 2.77 2.65 3.13 15.22
Dec 2.29 1.95 2.51 22.40

Petros Pharmaceuticals information and performance

Petros Pharmaceuticals Inc is a men’s health pharmaceutical company. It focuses on identifying, developing, acquiring, and commercializing innovative therapeutics for men’s health issues including erectile dysfunction, peyronie’s disease, hormone health and substance use disorders. The company’s operating segment includes Prescription Medications and Medical Devices. It generates maximum revenue from the Prescription Medications segment. The Prescription Medications segment consists primarily of operations related to Stendra, which is sold generally in the United States, and H100 for the treatment of Peyronie’s disease.

Petros Pharmaceuticals Address

1185 AVENUE OF THE AMERICAS, 3RD FLOOR, NEW YORK, NY, US

Market Capitalization: 19 650 500 $

Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.

EBITDA: - $

EBITDA is earnings before interest, income tax and depreciation of assets.

PE Ratio: None

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: None

Price/earnings to growth

DPS: N/A

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: N/A

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: -0.825

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A

Quarterly Revenue Growth YOY: -0.381

Trailing PE: -

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: -

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 0.6

Enterprise Value (EV) /Revenue

EV To EBITDA: 2.298

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 20684700

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A

Percent Insiders: N/A

Percent Institutions: N/A




Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.